UA125062C2 - Анти-tigit антигензв'язуючі білки і способи їх застосування - Google Patents

Info

Publication number

UA125062C2

UA125062C2 UAA201803610A UAA201803610A UA125062C2 UA 125062 C2 UA125062 C2 UA 125062C2 UA A201803610 A UAA201803610 A UA A201803610A UA A201803610 A UAA201803610 A UA A201803610A UA 125062 C2 UA125062 C2 UA 125062C2

Authority

UA

Ukraine

Prior art keywords

avr

zeo

sequence

sov

proposed

Prior art date

2015-10-01

Links

• Espacenet
• Global Dossier
• Discuss

• 102000025171 antigen binding proteins Human genes 0.000 title claims abstract description 473
• 108091000831 antigen binding proteins Proteins 0.000 title claims abstract description 473
• 238000000034 method Methods 0.000 title claims description 236
• 210000004027 cell Anatomy 0.000 claims description 230
• 230000027455 binding Effects 0.000 claims description 196
• 241000282414 Homo sapiens Species 0.000 claims description 148
• 239000000427 antigen Substances 0.000 claims description 126
• 102000036639 antigens Human genes 0.000 claims description 122
• 108091007433 antigens Proteins 0.000 claims description 122
• 239000003814 drug Substances 0.000 claims description 107
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 100
• 239000003795 chemical substances by application Substances 0.000 claims description 100
• 229940124597 therapeutic agent Drugs 0.000 claims description 100
• 206010028980 Neoplasm Diseases 0.000 claims description 78
• 239000008194 pharmaceutical composition Substances 0.000 claims description 77
• 238000012575 bio-layer interferometry Methods 0.000 claims description 73
• 150000007523 nucleic acids Chemical class 0.000 claims description 73
• 102000039446 nucleic acids Human genes 0.000 claims description 72
• 108020004707 nucleic acids Proteins 0.000 claims description 72
• 230000003993 interaction Effects 0.000 claims description 61
• 238000011282 treatment Methods 0.000 claims description 59
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 57
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 56
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 55
• 239000003446 ligand Substances 0.000 claims description 54
• 201000010099 disease Diseases 0.000 claims description 51
• 210000003162 effector t lymphocyte Anatomy 0.000 claims description 49
• 238000004458 analytical method Methods 0.000 claims description 48
• 230000007170 pathology Effects 0.000 claims description 47
• 201000011510 cancer Diseases 0.000 claims description 45
• 102000004127 Cytokines Human genes 0.000 claims description 42
• 108090000695 Cytokines Proteins 0.000 claims description 42
• 230000000694 effects Effects 0.000 claims description 42
• 210000003289 regulatory T cell Anatomy 0.000 claims description 41
• 229960002621 pembrolizumab Drugs 0.000 claims description 38
• 230000014509 gene expression Effects 0.000 claims description 37
• 238000004519 manufacturing process Methods 0.000 claims description 37
• 102000005962 receptors Human genes 0.000 claims description 33
• 108020003175 receptors Proteins 0.000 claims description 33
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 30
• 230000006870 function Effects 0.000 claims description 29
• 229920001184 polypeptide Polymers 0.000 claims description 28
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 28
• 210000002865 immune cell Anatomy 0.000 claims description 27
• 230000001965 increasing effect Effects 0.000 claims description 27
• -1 MABZ Proteins 0.000 claims description 26
• 239000000556 agonist Substances 0.000 claims description 25
• 239000012636 effector Substances 0.000 claims description 25
• YJSXHUXXMDAOCE-UHFFFAOYSA-N 5-hydroxy-8,8-dimethyl-6-(2-methylbutanoyl)-4-phenylpyrano[2,3-h]chromen-2-one Chemical compound C=1C(=O)OC=2C=3C=CC(C)(C)OC=3C(C(=O)C(C)CC)=C(O)C=2C=1C1=CC=CC=C1 YJSXHUXXMDAOCE-UHFFFAOYSA-N 0.000 claims description 24
• 230000011664 signaling Effects 0.000 claims description 23
• 241000282553 Macaca Species 0.000 claims description 22
• 244000309459 oncolytic virus Species 0.000 claims description 22
• 230000009471 action Effects 0.000 claims description 21
• 239000013598 vector Substances 0.000 claims description 21
• 108010002350 Interleukin-2 Proteins 0.000 claims description 20
• 102000000588 Interleukin-2 Human genes 0.000 claims description 20
• 235000013305 food Nutrition 0.000 claims description 15
• 108091008042 inhibitory receptors Proteins 0.000 claims description 15
• 230000004936 stimulating effect Effects 0.000 claims description 15
• 208000036142 Viral infection Diseases 0.000 claims description 14
• 230000009385 viral infection Effects 0.000 claims description 14
• 230000005764 inhibitory process Effects 0.000 claims description 13
• 108091033319 polynucleotide Proteins 0.000 claims description 13
• 102000040430 polynucleotide Human genes 0.000 claims description 13
• 239000002157 polynucleotide Substances 0.000 claims description 13
• 230000001629 suppression Effects 0.000 claims description 13
• 101100075830 Caenorhabditis elegans mab-5 gene Proteins 0.000 claims description 12
• 101100344898 Arabidopsis thaliana MED13 gene Proteins 0.000 claims description 11
• 101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 claims description 11
• 101100075831 Caenorhabditis elegans mab-7 gene Proteins 0.000 claims description 11
• 239000003022 immunostimulating agent Substances 0.000 claims description 11
• 101100022444 Mus musculus Mab21l1 gene Proteins 0.000 claims description 10
• 102000013462 Interleukin-12 Human genes 0.000 claims description 9
• 108010065805 Interleukin-12 Proteins 0.000 claims description 9
• 102000003812 Interleukin-15 Human genes 0.000 claims description 9
• 108090000172 Interleukin-15 Proteins 0.000 claims description 9
• 108010002586 Interleukin-7 Proteins 0.000 claims description 8
• 230000000903 blocking effect Effects 0.000 claims description 8
• 230000001404 mediated effect Effects 0.000 claims description 8
• ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 7
• 108010002616 Interleukin-5 Proteins 0.000 claims description 7
• 102100028749 Neuritin Human genes 0.000 claims description 7
• 101710189685 Neuritin Proteins 0.000 claims description 7
• 241000700584 Simplexvirus Species 0.000 claims description 7
• 241000711975 Vesicular stomatitis virus Species 0.000 claims description 7
• 229960003852 atezolizumab Drugs 0.000 claims description 7
• 230000028993 immune response Effects 0.000 claims description 7
• 238000002955 isolation Methods 0.000 claims description 7
• 229960003301 nivolumab Drugs 0.000 claims description 7
• 241000701161 unidentified adenovirus Species 0.000 claims description 7
• 244000005894 Albizia lebbeck Species 0.000 claims description 6
• 241000711404 Avian avulavirus 1 Species 0.000 claims description 6
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 6
• 101001036659 Paenarthrobacter nicotinovorans 4-methylaminobutanoate oxidase (formaldehyde-forming) Proteins 0.000 claims description 6
• 101710058551 RO-1 Proteins 0.000 claims description 6
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims description 6
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims description 6
• 241000700618 Vaccinia virus Species 0.000 claims description 6
• 238000002512 chemotherapy Methods 0.000 claims description 6
• 230000005855 radiation Effects 0.000 claims description 6
• 229960005486 vaccine Drugs 0.000 claims description 6
• 101100516975 Arabidopsis thaliana NPY1 gene Proteins 0.000 claims description 5
• 241001372913 Maraba virus Species 0.000 claims description 5
• WMPXPUYPYQKQCX-UHFFFAOYSA-N Sulfamonomethoxine Chemical compound C1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 WMPXPUYPYQKQCX-UHFFFAOYSA-N 0.000 claims description 5
• 229950002916 avelumab Drugs 0.000 claims description 5
• 229950009791 durvalumab Drugs 0.000 claims description 5
• 239000000816 peptidomimetic Substances 0.000 claims description 5
• 150000003384 small molecules Chemical class 0.000 claims description 5
• 229960005158 sulfamethizole Drugs 0.000 claims description 5
• VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical compound S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 claims description 5
• 229950003874 sulfamonomethoxine Drugs 0.000 claims description 5
• 241000282326 Felis catus Species 0.000 claims description 4
• 241001446467 Mama Species 0.000 claims description 4
• 230000001461 cytolytic effect Effects 0.000 claims description 4
• 238000002560 therapeutic procedure Methods 0.000 claims description 4
• NUQMXKCBSUXVTG-UHFFFAOYSA-N CN(CCNCc1cn(Cc2ccc(Cl)cc2)nn1)CCNc3ccnc4cc(Cl)ccc34 Chemical compound CN(CCNCc1cn(Cc2ccc(Cl)cc2)nn1)CCNc3ccnc4cc(Cl)ccc34 NUQMXKCBSUXVTG-UHFFFAOYSA-N 0.000 claims description 3
• 241000254173 Coleoptera Species 0.000 claims description 3
• 101001041541 Romalea microptera RO-1 Proteins 0.000 claims description 3
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 3
• 235000006732 Torreya nucifera Nutrition 0.000 claims description 3
• 244000111306 Torreya nucifera Species 0.000 claims description 3
• 230000008859 change Effects 0.000 claims description 3
• 229910052757 nitrogen Inorganic materials 0.000 claims description 3
• 229940043131 pyroglutamate Drugs 0.000 claims description 3
• 101100049050 Arabidopsis thaliana PVA41 gene Proteins 0.000 claims description 2
• 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 claims description 2
• 241000283014 Dama Species 0.000 claims description 2
• 102100021807 ER degradation-enhancing alpha-mannosidase-like protein 1 Human genes 0.000 claims description 2
• 241000287828 Gallus gallus Species 0.000 claims description 2
• 101000895701 Homo sapiens ER degradation-enhancing alpha-mannosidase-like protein 1 Proteins 0.000 claims description 2
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 claims description 2
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 claims description 2
• 241001611408 Nebo Species 0.000 claims description 2
• 241001659863 Panna Species 0.000 claims description 2
• 241000270506 Tupinambis Species 0.000 claims description 2
• JNSGIVNNHKGGRU-JYRVWZFOSA-N diethoxyphosphinothioyl (2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetate Chemical compound CCOP(=S)(OCC)OC(=O)C(=N/OC)\C1=CSC(N)=N1 JNSGIVNNHKGGRU-JYRVWZFOSA-N 0.000 claims description 2
• 150000002500 ions Chemical class 0.000 claims description 2
• 239000007788 liquid Substances 0.000 claims description 2
• 238000012423 maintenance Methods 0.000 claims description 2
• 244000241257 Cucumis melo Species 0.000 claims 4
• 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims 4
• FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 4
• 208000002874 Acne Vulgaris Diseases 0.000 claims 3
• 206010000496 acne Diseases 0.000 claims 3
• 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 claims 3
• 241000543381 Cliftonia monophylla Species 0.000 claims 2
• 241000698776 Duma Species 0.000 claims 2
• 241000468053 Obodhiang virus Species 0.000 claims 2
• 230000035939 shock Effects 0.000 claims 2
• WLNBMPZUVDTASE-HXIISURNSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;sulfuric acid Chemical compound [O-]S([O-])(=O)=O.O=C[C@H]([NH3+])[C@@H](O)[C@H](O)[C@H](O)CO.O=C[C@H]([NH3+])[C@@H](O)[C@H](O)[C@H](O)CO WLNBMPZUVDTASE-HXIISURNSA-N 0.000 claims 1
• NUMXHEUHHRTBQT-AATRIKPKSA-N 2,4-dimethoxy-1-[(e)-2-nitroethenyl]benzene Chemical compound COC1=CC=C(\C=C\[N+]([O-])=O)C(OC)=C1 NUMXHEUHHRTBQT-AATRIKPKSA-N 0.000 claims 1
• SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 claims 1
• XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 claims 1
• MCNQUWLLXZZZAC-UHFFFAOYSA-N 4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-n-piperidin-1-ylpyrazole-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=C(C#N)C(C(=O)NN2CCCCC2)=NN1C1=CC=C(Cl)C=C1Cl MCNQUWLLXZZZAC-UHFFFAOYSA-N 0.000 claims 1
• CUARLQDWYSRQDF-UHFFFAOYSA-N 5-Nitroacenaphthene Chemical compound C1CC2=CC=CC3=C2C1=CC=C3[N+](=O)[O-] CUARLQDWYSRQDF-UHFFFAOYSA-N 0.000 claims 1
• 241000238876 Acari Species 0.000 claims 1
• 240000000489 Agave utahensis Species 0.000 claims 1
• 241000272814 Anser sp. Species 0.000 claims 1
• 101100350216 Arabidopsis thaliana PDH2 gene Proteins 0.000 claims 1
• 241001133287 Artocarpus hirsutus Species 0.000 claims 1
• 241000271566 Aves Species 0.000 claims 1
• 241000143476 Bidens Species 0.000 claims 1
• 101100310222 Caenorhabditis briggsae she-1 gene Proteins 0.000 claims 1
• 101100043731 Caenorhabditis elegans syx-3 gene Proteins 0.000 claims 1
• 235000003913 Coccoloba uvifera Nutrition 0.000 claims 1
• 206010010071 Coma Diseases 0.000 claims 1
• 241001327708 Coriaria sarmentosa Species 0.000 claims 1
• 241001137251 Corvidae Species 0.000 claims 1
• 244000304337 Cuminum cyminum Species 0.000 claims 1
• 235000007129 Cuminum cyminum Nutrition 0.000 claims 1
• 206010011732 Cyst Diseases 0.000 claims 1
• 241001649081 Dina Species 0.000 claims 1
• 101100535673 Drosophila melanogaster Syn gene Proteins 0.000 claims 1
• 241001331845 Equus asinus x caballus Species 0.000 claims 1
• 108090000368 Fibroblast growth factor 8 Proteins 0.000 claims 1
• 244000182067 Fraxinus ornus Species 0.000 claims 1
• 235000002917 Fraxinus ornus Nutrition 0.000 claims 1
• 244000301682 Heliotropium curassavicum Species 0.000 claims 1
• 235000015854 Heliotropium curassavicum Nutrition 0.000 claims 1
• 241000258937 Hemiptera Species 0.000 claims 1
• 235000003332 Ilex aquifolium Nutrition 0.000 claims 1
• 241000209027 Ilex aquifolium Species 0.000 claims 1
• 241000764773 Inna Species 0.000 claims 1
• 244000071493 Iris tectorum Species 0.000 claims 1
• 241001397173 Kali <angiosperm> Species 0.000 claims 1
• 241000110847 Kochia Species 0.000 claims 1
• 241000824268 Kuma Species 0.000 claims 1
• 101000831624 Locusta migratoria Locustatachykinin-1 Proteins 0.000 claims 1
• 241001206439 Motya Species 0.000 claims 1
• 101100149256 Mus musculus Sema6b gene Proteins 0.000 claims 1
• 101100368134 Mus musculus Syn1 gene Proteins 0.000 claims 1
• 101100123718 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pda-1 gene Proteins 0.000 claims 1
• 101800001775 Nuclear inclusion protein A Proteins 0.000 claims 1
• 240000000220 Panda oleosa Species 0.000 claims 1
• 235000016496 Panda oleosa Nutrition 0.000 claims 1
• 235000008753 Papaver somniferum Nutrition 0.000 claims 1
• 241000218180 Papaveraceae Species 0.000 claims 1
• 241001674048 Phthiraptera Species 0.000 claims 1
• PJYYBCXMCWDUAZ-YKDQUOQBSA-N Ponasterone A Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@@](O)([C@@H](O)CCC(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 PJYYBCXMCWDUAZ-YKDQUOQBSA-N 0.000 claims 1
• 240000008976 Pterocarpus marsupium Species 0.000 claims 1
• 244000299461 Theobroma cacao Species 0.000 claims 1
• 235000009470 Theobroma cacao Nutrition 0.000 claims 1
• CCAZWUJBLXKBAY-ULZPOIKGSA-N Tutin Chemical compound C([C@]12[C@@H]3O[C@@H]3[C@@]3(O)[C@H]4C(=O)O[C@@H]([C@H]([C@]32C)O)[C@H]4C(=C)C)O1 CCAZWUJBLXKBAY-ULZPOIKGSA-N 0.000 claims 1
• 241001523432 Zale Species 0.000 claims 1
• 239000008186 active pharmaceutical agent Substances 0.000 claims 1
• 238000007664 blowing Methods 0.000 claims 1
• 235000021152 breakfast Nutrition 0.000 claims 1
• 208000031513 cyst Diseases 0.000 claims 1
• AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 claims 1
• 210000000936 intestine Anatomy 0.000 claims 1
• NXMXPVQZFYYPGD-UHFFFAOYSA-N methyl 2-methylprop-2-enoate;methyl prop-2-enoate Chemical compound COC(=O)C=C.COC(=O)C(C)=C NXMXPVQZFYYPGD-UHFFFAOYSA-N 0.000 claims 1
• 229910052754 neon Inorganic materials 0.000 claims 1
• GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 claims 1
• 235000010987 pectin Nutrition 0.000 claims 1
• 229920001277 pectin Polymers 0.000 claims 1
• 239000001814 pectin Substances 0.000 claims 1
• 244000062645 predators Species 0.000 claims 1
• MXRGZXBFSKSZPH-UHFFFAOYSA-N protheobromine Chemical compound O=C1N(CC(O)C)C(=O)N(C)C2=C1N(C)C=N2 MXRGZXBFSKSZPH-UHFFFAOYSA-N 0.000 claims 1
• 210000001747 pupil Anatomy 0.000 claims 1
• 235000011888 snacks Nutrition 0.000 claims 1
• 229940035289 tobi Drugs 0.000 claims 1
• NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 claims 1
• JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 claims 1
• 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 abstract 1
• 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 abstract 1
• 102000049823 human TIGIT Human genes 0.000 abstract 1
• 235000001014 amino acid Nutrition 0.000 description 83
• 238000006467 substitution reaction Methods 0.000 description 80
• 125000003275 alpha amino acid group Chemical group 0.000 description 76
• NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 74
• 108090000623 proteins and genes Proteins 0.000 description 49
• 102000004169 proteins and genes Human genes 0.000 description 44
• 241000700605 Viruses Species 0.000 description 43
• 235000018102 proteins Nutrition 0.000 description 43
• 239000012634 fragment Substances 0.000 description 42
• 241000699666 Mus <mouse, genus> Species 0.000 description 41
• 238000005259 measurement Methods 0.000 description 40
• 238000003556 assay Methods 0.000 description 37
• 239000000203 mixture Substances 0.000 description 37
• 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 36
• 108060003951 Immunoglobulin Proteins 0.000 description 25
• 230000003042 antagnostic effect Effects 0.000 description 25
• 102000018358 immunoglobulin Human genes 0.000 description 25
• 230000003308 immunostimulating effect Effects 0.000 description 24
• 230000009824 affinity maturation Effects 0.000 description 20
• 102100040247 Tumor necrosis factor Human genes 0.000 description 19
• 230000004913 activation Effects 0.000 description 18
• 241000256844 Apis mellifera Species 0.000 description 17
• 239000012131 assay buffer Substances 0.000 description 17
• 210000004602 germ cell Anatomy 0.000 description 17
• 238000010494 dissociation reaction Methods 0.000 description 16
• 230000005593 dissociations Effects 0.000 description 16
• 230000013595 glycosylation Effects 0.000 description 16
• 238000006206 glycosylation reaction Methods 0.000 description 16
• 239000000523 sample Substances 0.000 description 16
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 15
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 15
• 229910052698 phosphorus Inorganic materials 0.000 description 15
• 238000002708 random mutagenesis Methods 0.000 description 15
• 238000002741 site-directed mutagenesis Methods 0.000 description 15
• 239000000546 pharmaceutical excipient Substances 0.000 description 14
• 101100022187 Caenorhabditis elegans mab-10 gene Proteins 0.000 description 13
• 241000701022 Cytomegalovirus Species 0.000 description 13
• 229940024606 amino acid Drugs 0.000 description 13
• 150000001413 amino acids Chemical group 0.000 description 13
• 239000000872 buffer Substances 0.000 description 13
• 125000005647 linker group Chemical group 0.000 description 13
• 229920000642 polymer Polymers 0.000 description 13
• 210000001519 tissue Anatomy 0.000 description 13
• 235000010469 Glycine max Nutrition 0.000 description 11
• 102000001398 Granzyme Human genes 0.000 description 11
• 108060005986 Granzyme Proteins 0.000 description 11
• 241000282567 Macaca fascicularis Species 0.000 description 11
• 102000004503 Perforin Human genes 0.000 description 11
• 108010056995 Perforin Proteins 0.000 description 11
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 11
• 238000002474 experimental method Methods 0.000 description 11
• 230000002401 inhibitory effect Effects 0.000 description 11
• 229930192851 perforin Natural products 0.000 description 11
• 239000000243 solution Substances 0.000 description 11
• 230000001225 therapeutic effect Effects 0.000 description 11
• 125000000539 amino acid group Chemical group 0.000 description 10
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 10
• 150000002482 oligosaccharides Chemical class 0.000 description 10
• 230000006433 tumor necrosis factor production Effects 0.000 description 10
• 239000011534 wash buffer Substances 0.000 description 10
• 244000068988 Glycine max Species 0.000 description 9
• 108060001084 Luciferase Proteins 0.000 description 9
• 239000005089 Luciferase Substances 0.000 description 9
• 241000699670 Mus sp. Species 0.000 description 9
• 206010035226 Plasma cell myeloma Diseases 0.000 description 9
• 210000004271 bone marrow stromal cell Anatomy 0.000 description 9
• 238000010790 dilution Methods 0.000 description 9
• 239000012895 dilution Substances 0.000 description 9
• 210000004408 hybridoma Anatomy 0.000 description 9
• 230000001976 improved effect Effects 0.000 description 9
• 238000002347 injection Methods 0.000 description 9
• 239000007924 injection Substances 0.000 description 9
• 239000002609 medium Substances 0.000 description 9
• 230000035772 mutation Effects 0.000 description 9
• 229920001542 oligosaccharide Polymers 0.000 description 9
• 230000035755 proliferation Effects 0.000 description 9
• ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 8
• 239000000969 carrier Substances 0.000 description 8
• 150000001875 compounds Chemical class 0.000 description 8
• 238000000684 flow cytometry Methods 0.000 description 8
• 238000011534 incubation Methods 0.000 description 8
• 210000004698 lymphocyte Anatomy 0.000 description 8
• 239000003550 marker Substances 0.000 description 8
• PKAHQJNJPDVTDP-UHFFFAOYSA-N methyl cyclopropanecarboxylate Chemical compound COC(=O)C1CC1 PKAHQJNJPDVTDP-UHFFFAOYSA-N 0.000 description 8
• DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
• 201000000050 myeloid neoplasm Diseases 0.000 description 8
• 239000006201 parenteral dosage form Substances 0.000 description 8
• 229920001223 polyethylene glycol Polymers 0.000 description 8
• 238000002360 preparation method Methods 0.000 description 8
• 230000004044 response Effects 0.000 description 8
• 239000002904 solvent Substances 0.000 description 8
• 230000000638 stimulation Effects 0.000 description 8
• 244000117499 Colubrina elliptica Species 0.000 description 7
• 241000699800 Cricetinae Species 0.000 description 7
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 7
• 101100075837 Drosophila melanogaster Mabi gene Proteins 0.000 description 7
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
• 108010074328 Interferon-gamma Proteins 0.000 description 7
• 239000002202 Polyethylene glycol Substances 0.000 description 7
• 230000004071 biological effect Effects 0.000 description 7
• 239000002552 dosage form Substances 0.000 description 7
• 229940079593 drug Drugs 0.000 description 7
• RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
• 229940072221 immunoglobulins Drugs 0.000 description 7
• 239000003112 inhibitor Substances 0.000 description 7
• JZLFUUHOTZKEFU-UHFFFAOYSA-N methyl 4-azidobenzenecarboximidate Chemical compound COC(=N)C1=CC=C(N=[N+]=[N-])C=C1 JZLFUUHOTZKEFU-UHFFFAOYSA-N 0.000 description 7
• 230000004481 post-translational protein modification Effects 0.000 description 7
• 230000002062 proliferating effect Effects 0.000 description 7
• 238000010188 recombinant method Methods 0.000 description 7
• 241000894007 species Species 0.000 description 7
• 230000004083 survival effect Effects 0.000 description 7
• 238000012360 testing method Methods 0.000 description 7
• 241000283707 Capra Species 0.000 description 6
• 241000282693 Cercopithecidae Species 0.000 description 6
• 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 6
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 102000000704 Interleukin-7 Human genes 0.000 description 6
• 208000027066 STING-associated vasculopathy with onset in infancy Diseases 0.000 description 6
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 6
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
• 239000005557 antagonist Substances 0.000 description 6
• 238000012217 deletion Methods 0.000 description 6
• 230000037430 deletion Effects 0.000 description 6
• 231100000673 dose–response relationship Toxicity 0.000 description 6
• 230000012010 growth Effects 0.000 description 6
• 230000004073 interleukin-2 production Effects 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
• 230000002829 reductive effect Effects 0.000 description 6
• 239000006228 supernatant Substances 0.000 description 6
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 5
• IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 5
• 241000991587 Enterovirus C Species 0.000 description 5
• 102100037850 Interferon gamma Human genes 0.000 description 5
• 102100030703 Interleukin-22 Human genes 0.000 description 5
• 102000000743 Interleukin-5 Human genes 0.000 description 5
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
• 240000005546 Piper methysticum Species 0.000 description 5
• 235000016787 Piper methysticum Nutrition 0.000 description 5
• 241000700159 Rattus Species 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 238000004113 cell culture Methods 0.000 description 5
• 238000011198 co-culture assay Methods 0.000 description 5
• 108091008034 costimulatory receptors Proteins 0.000 description 5
• 235000018417 cysteine Nutrition 0.000 description 5
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
• 229940127089 cytotoxic agent Drugs 0.000 description 5
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
• 208000035475 disorder Diseases 0.000 description 5
• 108010074108 interleukin-21 Proteins 0.000 description 5
• 230000000670 limiting effect Effects 0.000 description 5
• 229940124531 pharmaceutical excipient Drugs 0.000 description 5
• 230000002265 prevention Effects 0.000 description 5
• 238000000746 purification Methods 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 230000003612 virological effect Effects 0.000 description 5
• GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 4
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 4
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 4
• 241000282472 Canis lupus familiaris Species 0.000 description 4
• SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 4
• PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 4
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
• 101001043564 Homo sapiens Prolow-density lipoprotein receptor-related protein 1 Proteins 0.000 description 4
• 108090001005 Interleukin-6 Proteins 0.000 description 4
• 102000004889 Interleukin-6 Human genes 0.000 description 4
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 4
• SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 4
• 239000004472 Lysine Substances 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 4
• 102100026933 Myelin-associated neurite-outgrowth inhibitor Human genes 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 239000004698 Polyethylene Substances 0.000 description 4
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 4
• 102100021923 Prolow-density lipoprotein receptor-related protein 1 Human genes 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
• 235000004279 alanine Nutrition 0.000 description 4
• 239000002518 antifoaming agent Substances 0.000 description 4
• 238000000508 aqueous-phase reforming Methods 0.000 description 4
• 210000003719 b-lymphocyte Anatomy 0.000 description 4
• 230000000295 complement effect Effects 0.000 description 4
• 229920001577 copolymer Polymers 0.000 description 4
• 239000000824 cytostatic agent Substances 0.000 description 4
• 230000007423 decrease Effects 0.000 description 4
• 238000005516 engineering process Methods 0.000 description 4
• 235000019441 ethanol Nutrition 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• 210000000987 immune system Anatomy 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 239000006166 lysate Substances 0.000 description 4
• 230000035800 maturation Effects 0.000 description 4
• 239000002957 persistent organic pollutant Substances 0.000 description 4
• YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
• 230000000770 proinflammatory effect Effects 0.000 description 4
• 230000028327 secretion Effects 0.000 description 4
• 230000009870 specific binding Effects 0.000 description 4
• 238000010186 staining Methods 0.000 description 4
• 238000011272 standard treatment Methods 0.000 description 4
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 4
• 239000004094 surface-active agent Substances 0.000 description 4
• 235000013616 tea Nutrition 0.000 description 4
• KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 3
• VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 3
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
• 101100257262 Caenorhabditis elegans soc-1 gene Proteins 0.000 description 3
• 101100540120 Caenorhabditis elegans vab-3 gene Proteins 0.000 description 3
• 206010009944 Colon cancer Diseases 0.000 description 3
• 241000710188 Encephalomyocarditis virus Species 0.000 description 3
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 3
• 108090000174 Interleukin-10 Proteins 0.000 description 3
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• 101100491259 Oryza sativa subsp. japonica AP2-2 gene Proteins 0.000 description 3
• 241000288906 Primates Species 0.000 description 3
• 108010076504 Protein Sorting Signals Proteins 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 108091008874 T cell receptors Proteins 0.000 description 3
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 3
• 239000004473 Threonine Substances 0.000 description 3
• WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
• 239000003242 anti bacterial agent Substances 0.000 description 3
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 3
• 239000002246 antineoplastic agent Substances 0.000 description 3
• 235000009582 asparagine Nutrition 0.000 description 3
• 229960001230 asparagine Drugs 0.000 description 3
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
• 238000004166 bioassay Methods 0.000 description 3
• WWVKQTNONPWVEL-UHFFFAOYSA-N caffeic acid phenethyl ester Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCC1=CC=CC=C1 WWVKQTNONPWVEL-UHFFFAOYSA-N 0.000 description 3
• 150000001720 carbohydrates Chemical group 0.000 description 3
• 210000004671 cell-free system Anatomy 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 238000002648 combination therapy Methods 0.000 description 3
• 239000000356 contaminant Substances 0.000 description 3
• 239000012228 culture supernatant Substances 0.000 description 3
• 230000016396 cytokine production Effects 0.000 description 3
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
• 230000001472 cytotoxic effect Effects 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 235000014113 dietary fatty acids Nutrition 0.000 description 3
• 230000004069 differentiation Effects 0.000 description 3
• 239000000539 dimer Substances 0.000 description 3
• 238000006471 dimerization reaction Methods 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 210000003527 eukaryotic cell Anatomy 0.000 description 3
• 229930195729 fatty acid Natural products 0.000 description 3
• 239000000194 fatty acid Substances 0.000 description 3
• 229960002949 fluorouracil Drugs 0.000 description 3
• VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 3
• 235000008191 folinic acid Nutrition 0.000 description 3
• 239000011672 folinic acid Substances 0.000 description 3
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
• 201000005787 hematologic cancer Diseases 0.000 description 3
• 239000005556 hormone Substances 0.000 description 3
• 229940088597 hormone Drugs 0.000 description 3
• 229940127121 immunoconjugate Drugs 0.000 description 3
• 238000003780 insertion Methods 0.000 description 3
• 230000037431 insertion Effects 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 229960001691 leucovorin Drugs 0.000 description 3
• 238000011068 loading method Methods 0.000 description 3
• 210000003071 memory t lymphocyte Anatomy 0.000 description 3
• 108091070501 miRNA Proteins 0.000 description 3
• 239000011859 microparticle Substances 0.000 description 3
• JLESVLCTIOAHPT-UHFFFAOYSA-N mmai Chemical compound C1=C(C)C(OC)=CC2=C1CC(N)C2 JLESVLCTIOAHPT-UHFFFAOYSA-N 0.000 description 3
• 206010051747 multiple endocrine neoplasia Diseases 0.000 description 3
• 238000002703 mutagenesis Methods 0.000 description 3
• 231100000350 mutagenesis Toxicity 0.000 description 3
• 239000002105 nanoparticle Substances 0.000 description 3
• 238000004806 packaging method and process Methods 0.000 description 3
• 230000037361 pathway Effects 0.000 description 3
• 235000013550 pizza Nutrition 0.000 description 3
• 229920001451 polypropylene glycol Polymers 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 210000001236 prokaryotic cell Anatomy 0.000 description 3
• 230000000069 prophylactic effect Effects 0.000 description 3
• 238000000159 protein binding assay Methods 0.000 description 3
• 108020001580 protein domains Proteins 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 238000012216 screening Methods 0.000 description 3
• 238000002864 sequence alignment Methods 0.000 description 3
• 239000011734 sodium Substances 0.000 description 3
• 235000000346 sugar Nutrition 0.000 description 3
• 208000024891 symptom Diseases 0.000 description 3
• 108060008226 thioredoxin Proteins 0.000 description 3
• 229940104230 thymidine Drugs 0.000 description 3
• 210000005253 yeast cell Anatomy 0.000 description 3
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
• YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
• XFDUHJPVQKIXHO-UHFFFAOYSA-N 3-aminobenzoic acid Chemical compound NC1=CC=CC(C(O)=O)=C1 XFDUHJPVQKIXHO-UHFFFAOYSA-N 0.000 description 2
• 206010000830 Acute leukaemia Diseases 0.000 description 2
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
• 229920000936 Agarose Polymers 0.000 description 2
• 101100058739 Arabidopsis thaliana BZR2 gene Proteins 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 102100031077 Calcineurin B homologous protein 3 Human genes 0.000 description 2
• 241000700626 Cowpox virus Species 0.000 description 2
• 235000017788 Cydonia oblonga Nutrition 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
• 108020004414 DNA Proteins 0.000 description 2
• 241000255925 Diptera Species 0.000 description 2
• 101100234002 Drosophila melanogaster Shal gene Proteins 0.000 description 2
• 241000283086 Equidae Species 0.000 description 2
• 241000283073 Equus caballus Species 0.000 description 2
• 102100037362 Fibronectin Human genes 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• 235000008100 Ginkgo biloba Nutrition 0.000 description 2
• 244000194101 Ginkgo biloba Species 0.000 description 2
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• 229920002907 Guar gum Polymers 0.000 description 2
• 241000711549 Hepacivirus C Species 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 102000012745 Immunoglobulin Subunits Human genes 0.000 description 2
• 108010079585 Immunoglobulin Subunits Proteins 0.000 description 2
• 102000008070 Interferon-gamma Human genes 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 2
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 2
• 241000989747 Maba Species 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 102000004855 Multi drug resistance-associated proteins Human genes 0.000 description 2
• 108090001099 Multi drug resistance-associated proteins Proteins 0.000 description 2
• 208000005647 Mumps Diseases 0.000 description 2
• 101100498160 Mus musculus Dach1 gene Proteins 0.000 description 2
• 102100038750 Myc-associated zinc finger protein Human genes 0.000 description 2
• 101710146400 Myc-associated zinc finger protein Proteins 0.000 description 2
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 229930012538 Paclitaxel Natural products 0.000 description 2
• 108090000526 Papain Proteins 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 108010079855 Peptide Aptamers Proteins 0.000 description 2
• 241001505332 Polyomavirus sp. Species 0.000 description 2
• 239000004372 Polyvinyl alcohol Substances 0.000 description 2
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
• NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
• 235000015076 Shorea robusta Nutrition 0.000 description 2
• 244000166071 Shorea robusta Species 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• 235000018650 Solanum gilo Nutrition 0.000 description 2
• 244000258044 Solanum gilo Species 0.000 description 2
• 208000005718 Stomach Neoplasms Diseases 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• 229940123237 Taxane Drugs 0.000 description 2
• 208000024313 Testicular Neoplasms Diseases 0.000 description 2
• 206010057644 Testis cancer Diseases 0.000 description 2
• 102100036407 Thioredoxin Human genes 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• 208000024770 Thyroid neoplasm Diseases 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 230000002411 adverse Effects 0.000 description 2
• 238000001042 affinity chromatography Methods 0.000 description 2
• 230000008485 antagonism Effects 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 230000000890 antigenic effect Effects 0.000 description 2
• 239000013059 antihormonal agent Substances 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
• 230000008512 biological response Effects 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 229940098773 bovine serum albumin Drugs 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• 229960004562 carboplatin Drugs 0.000 description 2
• 239000013592 cell lysate Substances 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 208000029742 colonic neoplasm Diseases 0.000 description 2
• 230000002301 combined effect Effects 0.000 description 2
• 239000000562 conjugate Substances 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 238000012937 correction Methods 0.000 description 2
• 201000003740 cowpox Diseases 0.000 description 2
• 238000012258 culturing Methods 0.000 description 2
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
• 239000002254 cytotoxic agent Substances 0.000 description 2
• 231100000599 cytotoxic agent Toxicity 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 239000012502 diagnostic product Substances 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 238000004090 dissolution Methods 0.000 description 2
• POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
• 210000005069 ears Anatomy 0.000 description 2
• 238000012874 electrostatic modification Methods 0.000 description 2
• 206010014599 encephalitis Diseases 0.000 description 2
• 239000013604 expression vector Substances 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 150000004665 fatty acids Chemical class 0.000 description 2
• 150000002191 fatty alcohols Chemical class 0.000 description 2
• 239000000945 filler Substances 0.000 description 2
• 230000033581 fucosylation Effects 0.000 description 2
• 229930182830 galactose Natural products 0.000 description 2
• 101150077246 gas5 gene Proteins 0.000 description 2
• 206010017758 gastric cancer Diseases 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• 239000011521 glass Substances 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• 235000013922 glutamic acid Nutrition 0.000 description 2
• 239000004220 glutamic acid Substances 0.000 description 2
• 235000011187 glycerol Nutrition 0.000 description 2
• 239000000665 guar gum Substances 0.000 description 2
• 235000010417 guar gum Nutrition 0.000 description 2
• 229960002154 guar gum Drugs 0.000 description 2
• 229920001519 homopolymer Polymers 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 229960003130 interferon gamma Drugs 0.000 description 2
• 230000002601 intratumoral effect Effects 0.000 description 2
• 229960004768 irinotecan Drugs 0.000 description 2
• UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 2
• 210000003292 kidney cell Anatomy 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
• 238000013507 mapping Methods 0.000 description 2
• 229930182817 methionine Natural products 0.000 description 2
• 235000006109 methionine Nutrition 0.000 description 2
• 238000003032 molecular docking Methods 0.000 description 2
• 208000010805 mumps infectious disease Diseases 0.000 description 2
• 210000000822 natural killer cell Anatomy 0.000 description 2
• 238000011330 nucleic acid test Methods 0.000 description 2
• 239000003921 oil Substances 0.000 description 2
• 235000019198 oils Nutrition 0.000 description 2
• 229960001756 oxaliplatin Drugs 0.000 description 2
• DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 2
• 238000007254 oxidation reaction Methods 0.000 description 2
• 229960001592 paclitaxel Drugs 0.000 description 2
• 229940055729 papain Drugs 0.000 description 2
• 235000019834 papain Nutrition 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
• 210000001322 periplasm Anatomy 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 239000002953 phosphate buffered saline Substances 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229910052697 platinum Inorganic materials 0.000 description 2
• 229920002451 polyvinyl alcohol Polymers 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 201000011549 stomach cancer Diseases 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
• 201000003120 testicular cancer Diseases 0.000 description 2
• HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
• 229940094937 thioredoxin Drugs 0.000 description 2
• 201000002510 thyroid cancer Diseases 0.000 description 2
• 238000003146 transient transfection Methods 0.000 description 2
• 210000004881 tumor cell Anatomy 0.000 description 2
• 238000000108 ultra-filtration Methods 0.000 description 2
• 238000005406 washing Methods 0.000 description 2
• 239000008215 water for injection Substances 0.000 description 2
• 229920003169 water-soluble polymer Polymers 0.000 description 2
• 239000001993 wax Substances 0.000 description 2
• 239000008434 yi-zhi Substances 0.000 description 2
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
• FBOUIAKEJMZPQG-AWNIVKPZSA-N (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-AWNIVKPZSA-N 0.000 description 1
• UNEAIINSYNBMRP-QAYSAQNBSA-N (2r,3r)-5-(methylamino)-3-(4-phenylpiperidin-1-yl)-1,2,3,4-tetrahydronaphthalen-2-ol Chemical compound C1CN([C@H]2[C@H](O)CC=3C=CC=C(C=3C2)N[11CH3])CCC1C1=CC=CC=C1 UNEAIINSYNBMRP-QAYSAQNBSA-N 0.000 description 1
• ZEDFYFVAXSGTGU-RPZXMPESSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ZEDFYFVAXSGTGU-RPZXMPESSA-N 0.000 description 1
• KYBXNPIASYUWLN-WUCPZUCCSA-N (2s)-5-hydroxypyrrolidine-2-carboxylic acid Chemical compound OC1CC[C@@H](C(O)=O)N1 KYBXNPIASYUWLN-WUCPZUCCSA-N 0.000 description 1
• YTOHLXIXCGJIOG-HDXRNPEWSA-N (2s,6r,9s,12r,13s)-13-hydroxy-6-methyl-12-propan-2-yl-2-[(e)-4-sulfanylbut-1-enyl]-9-(sulfanylmethyl)-1-oxa-5,8,11-triazacyclopentadecane-4,7,10,15-tetrone Chemical compound CC(C)[C@H]1NC(=O)[C@@H](CS)NC(=O)[C@@H](C)NC(=O)C[C@@H](\C=C\CCS)OC(=O)C[C@@H]1O YTOHLXIXCGJIOG-HDXRNPEWSA-N 0.000 description 1
• ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
• BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 1
• WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
• WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
• OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
• LJJFNFYPZOHRHM-UHFFFAOYSA-N 1-isocyano-2-methoxy-2-methylpropane Chemical compound COC(C)(C)C[N+]#[C-] LJJFNFYPZOHRHM-UHFFFAOYSA-N 0.000 description 1
• 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
• RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
• TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
• HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
• 229940117976 5-hydroxylysine Drugs 0.000 description 1
• 241001519451 Abramis brama Species 0.000 description 1
• 235000006491 Acacia senegal Nutrition 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 208000006468 Adrenal Cortex Neoplasms Diseases 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 241001036151 Aichi virus 1 Species 0.000 description 1
• 108700032845 Ala(2)- enkephalinamide-Met Proteins 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 241000388165 Alphapapillomavirus 4 Species 0.000 description 1
• 241000572565 Alpinia oxyphylla Species 0.000 description 1
• 206010061424 Anal cancer Diseases 0.000 description 1
• 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 1
• 108010049777 Ankyrins Proteins 0.000 description 1
• 102000008102 Ankyrins Human genes 0.000 description 1
• 241000272517 Anseriformes Species 0.000 description 1
• 208000007860 Anus Neoplasms Diseases 0.000 description 1
• 206010073360 Appendix cancer Diseases 0.000 description 1
• 108091023037 Aptamer Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 208000002109 Argyria Diseases 0.000 description 1
• 206010003402 Arthropod sting Diseases 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 241000295638 Australian bat lyssavirus Species 0.000 description 1
• 241001057406 Azya Species 0.000 description 1
• 241001302512 Banna virus Species 0.000 description 1
• 206010004146 Basal cell carcinoma Diseases 0.000 description 1
• 206010004593 Bile duct cancer Diseases 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
• 241000283725 Bos Species 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 241001300938 Brya Species 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 1
• 101100115215 Caenorhabditis elegans cul-2 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000282832 Camelidae Species 0.000 description 1
• 241000282836 Camelus dromedarius Species 0.000 description 1
• GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 1
• GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 102000005367 Carboxypeptidases Human genes 0.000 description 1
• 108010006303 Carboxypeptidases Proteins 0.000 description 1
• 208000005623 Carcinogenesis Diseases 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 244000146553 Ceiba pentandra Species 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
• 108010078239 Chemokine CX3CL1 Proteins 0.000 description 1
• 102000014464 Chemokine CX3CL1 Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 241001502567 Chikungunya virus Species 0.000 description 1
• 241000288673 Chiroptera Species 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 101100500421 Chlamydomonas reinhardtii DHC1 gene Proteins 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• 201000009047 Chordoma Diseases 0.000 description 1
• 101150065749 Churc1 gene Proteins 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 235000006481 Colocasia esculenta Nutrition 0.000 description 1
• 244000205754 Colocasia esculenta Species 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 241000033566 Cosavirus A Species 0.000 description 1
• 241000709687 Coxsackievirus Species 0.000 description 1
• 208000009798 Craniopharyngioma Diseases 0.000 description 1
• 241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 description 1
• 244000019459 Cynara cardunculus Species 0.000 description 1
• 235000019106 Cynara scolymus Nutrition 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 101000616562 Danio rerio Sonic hedgehog protein A Proteins 0.000 description 1
• 241000632511 Daviesia arborea Species 0.000 description 1
• 241000725619 Dengue virus Species 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 241000712471 Dhori virus Species 0.000 description 1
• 101100256884 Dictyostelium discoideum shkE gene Proteins 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 101100291267 Drosophila melanogaster Miga gene Proteins 0.000 description 1
• 101100369915 Drosophila melanogaster stas gene Proteins 0.000 description 1
• 208000006402 Ductal Carcinoma Diseases 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• 241001520695 Duvenhage lyssavirus Species 0.000 description 1
• 239000001692 EU approved anti-caking agent Substances 0.000 description 1
• 241000710945 Eastern equine encephalitis virus Species 0.000 description 1
• 241001115402 Ebolavirus Species 0.000 description 1
• 235000008247 Echinochloa frumentacea Nutrition 0.000 description 1
• 241001466953 Echovirus Species 0.000 description 1
• 235000009245 Elaeagnus multiflora Nutrition 0.000 description 1
• 240000000298 Elaeagnus multiflora Species 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 102100023688 Eotaxin Human genes 0.000 description 1
• 101710139422 Eotaxin Proteins 0.000 description 1
• 102400001368 Epidermal growth factor Human genes 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 241000283074 Equus asinus Species 0.000 description 1
• 101100105449 Escherichia coli (strain K12) yagE gene Proteins 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 208000006168 Ewing Sarcoma Diseases 0.000 description 1
• 201000008808 Fibrosarcoma Diseases 0.000 description 1
• 206010053717 Fibrous histiocytoma Diseases 0.000 description 1
• 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
• 102100032518 Gamma-crystallin B Human genes 0.000 description 1
• 101710092798 Gamma-crystallin B Proteins 0.000 description 1
• 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
• 206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 1
• 241001547860 Gaya Species 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 244000060234 Gmelina philippensis Species 0.000 description 1
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
• 206010066476 Haematological malignancy Diseases 0.000 description 1
• 241000825469 Haemulon vittatum Species 0.000 description 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
• 241000893570 Hendra henipavirus Species 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 241000724675 Hepatitis E virus Species 0.000 description 1
• 241000724709 Hepatitis delta virus Species 0.000 description 1
• 241000709721 Hepatovirus A Species 0.000 description 1
• 102100032822 Homeodomain-interacting protein kinase 1 Human genes 0.000 description 1
• 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 1
• 101001066404 Homo sapiens Homeodomain-interacting protein kinase 1 Proteins 0.000 description 1
• 101000852539 Homo sapiens Importin-5 Proteins 0.000 description 1
• 101000578476 Homo sapiens Latexin Proteins 0.000 description 1
• 101100520508 Homo sapiens PMVK gene Proteins 0.000 description 1
• 101000891367 Homo sapiens Transcobalamin-1 Proteins 0.000 description 1
• 101100018419 Hordeum vulgare IDS3 gene Proteins 0.000 description 1
• 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
• 241000598171 Human adenovirus sp. Species 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
• 241001479210 Human astrovirus Species 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 241000701041 Human betaherpesvirus 7 Species 0.000 description 1
• 241001207270 Human enterovirus Species 0.000 description 1
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
• 241001502974 Human gammaherpesvirus 8 Species 0.000 description 1
• 101000999691 Human herpesvirus 2 Transcriptional regulator ICP22 homolog Proteins 0.000 description 1
• 241000701027 Human herpesvirus 6 Species 0.000 description 1
• 241000725303 Human immunodeficiency virus Species 0.000 description 1
• 241000711920 Human orthopneumovirus Species 0.000 description 1
• 241000701806 Human papillomavirus Species 0.000 description 1
• 241000430519 Human rhinovirus sp. Species 0.000 description 1
• 241000714192 Human spumaretrovirus Species 0.000 description 1
• 241000947839 Human torovirus Species 0.000 description 1
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
• SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
• 102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 101150022794 IDS2 gene Proteins 0.000 description 1
• 101150042084 Ido2 gene Proteins 0.000 description 1
• 101710110377 Immediate early protein IE1 Proteins 0.000 description 1
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
• 102100036340 Importin-5 Human genes 0.000 description 1
• 235000020853 Inedia Nutrition 0.000 description 1
• 241000712431 Influenza A virus Species 0.000 description 1
• 241000713196 Influenza B virus Species 0.000 description 1
• 241000713297 Influenza C virus Species 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 206010061252 Intraocular melanoma Diseases 0.000 description 1
• 208000009164 Islet Cell Adenoma Diseases 0.000 description 1
• 241001611138 Isma Species 0.000 description 1
• 241000710842 Japanese encephalitis virus Species 0.000 description 1
• 208000007766 Kaposi sarcoma Diseases 0.000 description 1
• 230000005374 Kerr effect Effects 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 238000006165 Knowles reaction Methods 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 201000005099 Langerhans cell histiocytosis Diseases 0.000 description 1
• 241000712902 Lassa mammarenavirus Species 0.000 description 1
• 239000005639 Lauric acid Substances 0.000 description 1
• 101100121695 Leucosceptrum canum GFDPS gene Proteins 0.000 description 1
• 102000019298 Lipocalin Human genes 0.000 description 1
• 108050006654 Lipocalin Proteins 0.000 description 1
• 241001635205 Lordsdale virus Species 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 1
• 206010052178 Lymphocytic lymphoma Diseases 0.000 description 1
• 241000711828 Lyssavirus Species 0.000 description 1
• 101150033052 MAS5 gene Proteins 0.000 description 1
• 241000712898 Machupo mammarenavirus Species 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 description 1
• 206010073059 Malignant neoplasm of unknown primary site Diseases 0.000 description 1
• 208000032271 Malignant tumor of penis Diseases 0.000 description 1
• 239000005913 Maltodextrin Substances 0.000 description 1
• 229920002774 Maltodextrin Polymers 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 206010026749 Mania Diseases 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 241000608292 Mayaro virus Species 0.000 description 1
• 241000712079 Measles morbillivirus Species 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 208000002030 Merkel cell carcinoma Diseases 0.000 description 1
• 206010027406 Mesothelioma Diseases 0.000 description 1
• 206010063569 Metastatic squamous cell carcinoma Diseases 0.000 description 1
• 241000700627 Monkeypox virus Species 0.000 description 1
• 208000003445 Mouth Neoplasms Diseases 0.000 description 1
• 208000034578 Multiple myelomas Diseases 0.000 description 1
• 241000358374 Mupapillomavirus 1 Species 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
• FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
• OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
• OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
• ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
• 206010028729 Nasal cavity cancer Diseases 0.000 description 1
• 108060005251 Nectin Proteins 0.000 description 1
• 102100035488 Nectin-2 Human genes 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 206010029266 Neuroendocrine carcinoma of the skin Diseases 0.000 description 1
• 241000168432 New York hantavirus Species 0.000 description 1
• 241000526636 Nipah henipavirus Species 0.000 description 1
• 241000714209 Norwalk virus Species 0.000 description 1
• 230000004989 O-glycosylation Effects 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 208000000160 Olfactory Esthesioneuroblastoma Diseases 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 241000277269 Oncorhynchus masou Species 0.000 description 1
• 239000008896 Opium Substances 0.000 description 1
• 206010031096 Oropharyngeal cancer Diseases 0.000 description 1
• 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 102100036201 Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial Human genes 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 240000004072 Panicum sumatrense Species 0.000 description 1
• 241000282320 Panthera leo Species 0.000 description 1
• 206010061332 Paraganglion neoplasm Diseases 0.000 description 1
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 208000002471 Penile Neoplasms Diseases 0.000 description 1
• 206010034299 Penile cancer Diseases 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 102100035917 Peripheral myelin protein 22 Human genes 0.000 description 1
• 101710199257 Peripheral myelin protein 22 Proteins 0.000 description 1
• 208000037581 Persistent Infection Diseases 0.000 description 1
• 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
• 206010034811 Pharyngeal cancer Diseases 0.000 description 1
• 102100024279 Phosphomevalonate kinase Human genes 0.000 description 1
• 241001483078 Phyto Species 0.000 description 1
• 241000712910 Pichinde mammarenavirus Species 0.000 description 1
• 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
• 201000008199 Pleuropulmonary blastoma Diseases 0.000 description 1
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 241000125945 Protoparvovirus Species 0.000 description 1
• 241000150264 Puumala orthohantavirus Species 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
• 241000711798 Rabies lyssavirus Species 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 201000000582 Retinoblastoma Diseases 0.000 description 1
• 208000008938 Rhabdoid tumor Diseases 0.000 description 1
• 206010073334 Rhabdoid tumour Diseases 0.000 description 1
• 241000713124 Rift Valley fever virus Species 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 235000004789 Rosa xanthina Nutrition 0.000 description 1
• 241000109329 Rosa xanthina Species 0.000 description 1
• 241000405729 Rosavirus A Species 0.000 description 1
• 241001137860 Rotavirus A Species 0.000 description 1
• 241001137861 Rotavirus B Species 0.000 description 1
• 241001506005 Rotavirus C Species 0.000 description 1
• 241000710799 Rubella virus Species 0.000 description 1
• 101100451406 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HPM1 gene Proteins 0.000 description 1
• 101100344462 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YDJ1 gene Proteins 0.000 description 1
• 208000004337 Salivary Gland Neoplasms Diseases 0.000 description 1
• 206010061934 Salivary gland cancer Diseases 0.000 description 1
• 241000033084 Salivirus A Species 0.000 description 1
• 244000151637 Sambucus canadensis Species 0.000 description 1
• 235000018735 Sambucus canadensis Nutrition 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 241000710961 Semliki Forest virus Species 0.000 description 1
• 241000150278 Seoul orthohantavirus Species 0.000 description 1
• 241000270295 Serpentes Species 0.000 description 1
• 244000000231 Sesamum indicum Species 0.000 description 1
• 208000009359 Sezary Syndrome Diseases 0.000 description 1
• 229940122605 Short-acting muscarinic antagonist Drugs 0.000 description 1
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
• 241000710960 Sindbis virus Species 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 206010041067 Small cell lung cancer Diseases 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
• 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
• 239000004147 Sorbitan trioleate Substances 0.000 description 1
• PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
• 241000714208 Southampton virus Species 0.000 description 1
• 241000269319 Squalius cephalus Species 0.000 description 1
• 241000710888 St. Louis encephalitis virus Species 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 241001655798 Taku Species 0.000 description 1
• 241000120020 Tela Species 0.000 description 1
• 206010043276 Teratoma Diseases 0.000 description 1
• 102100024554 Tetranectin Human genes 0.000 description 1
• 244000269722 Thea sinensis Species 0.000 description 1
• 206010043515 Throat cancer Diseases 0.000 description 1
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
• 241000935372 Tisias Species 0.000 description 1
• JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 description 1
• 208000023915 Ureteral Neoplasms Diseases 0.000 description 1
• 206010046392 Ureteric cancer Diseases 0.000 description 1
• 206010046431 Urethral cancer Diseases 0.000 description 1
• 206010046458 Urethral neoplasms Diseases 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 208000002495 Uterine Neoplasms Diseases 0.000 description 1
• 201000005969 Uveal melanoma Diseases 0.000 description 1
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 1
• 208000028227 Viral hemorrhagic fever Diseases 0.000 description 1
• 208000010094 Visna Diseases 0.000 description 1
• 229930003427 Vitamin E Natural products 0.000 description 1
• 206010047741 Vulval cancer Diseases 0.000 description 1
• 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
• 241000710886 West Nile virus Species 0.000 description 1
• 208000008383 Wilms tumor Diseases 0.000 description 1
• 240000001781 Xanthosoma sagittifolium Species 0.000 description 1
• 241000710772 Yellow fever virus Species 0.000 description 1
• 241001178076 Zaga Species 0.000 description 1
• 241000209149 Zea Species 0.000 description 1
• 241000907316 Zika virus Species 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 230000008484 agonism Effects 0.000 description 1
• 235000001513 akia Nutrition 0.000 description 1
• 238000012867 alanine scanning Methods 0.000 description 1
• 125000003158 alcohol group Chemical group 0.000 description 1
• 150000005215 alkyl ethers Chemical class 0.000 description 1
• 229940087168 alpha tocopherol Drugs 0.000 description 1
• 229960003896 aminopterin Drugs 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 239000004037 angiogenesis inhibitor Substances 0.000 description 1
• 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
• 229940125364 angiotensin receptor blocker Drugs 0.000 description 1
• 230000005888 antibody-dependent cellular phagocytosis Effects 0.000 description 1
• 210000000628 antibody-producing cell Anatomy 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 201000011165 anus cancer Diseases 0.000 description 1
• 208000021780 appendiceal neoplasm Diseases 0.000 description 1
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 235000016520 artichoke thistle Nutrition 0.000 description 1
• 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 238000010009 beating Methods 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 208000001119 benign fibrous histiocytoma Diseases 0.000 description 1
• 229960000686 benzalkonium chloride Drugs 0.000 description 1
• UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
• 229960001950 benzethonium chloride Drugs 0.000 description 1
• 229960002903 benzyl benzoate Drugs 0.000 description 1
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 208000026900 bile duct neoplasm Diseases 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 229960000074 biopharmaceutical Drugs 0.000 description 1
• 235000007123 blue elder Nutrition 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 238000009835 boiling Methods 0.000 description 1
• 244000275904 brauner Senf Species 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• 230000005907 cancer growth Effects 0.000 description 1
• 229960004117 capecitabine Drugs 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• JGPOSNWWINVNFV-UHFFFAOYSA-N carboxyfluorescein diacetate succinimidyl ester Chemical group C=1C(OC(=O)C)=CC=C2C=1OC1=CC(OC(C)=O)=CC=C1C2(C1=C2)OC(=O)C1=CC=C2C(=O)ON1C(=O)CCC1=O JGPOSNWWINVNFV-UHFFFAOYSA-N 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 210000005056 cell body Anatomy 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 238000003570 cell viability assay Methods 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 229960002798 cetrimide Drugs 0.000 description 1
• 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
• YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
• 235000013351 cheese Nutrition 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 208000006990 cholangiocarcinoma Diseases 0.000 description 1
• 238000011098 chromatofocusing Methods 0.000 description 1
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
• 229960004316 cisplatin Drugs 0.000 description 1
• 238000004140 cleaning Methods 0.000 description 1
• 238000003501 co-culture Methods 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 230000024203 complement activation Effects 0.000 description 1
• 230000004154 complement system Effects 0.000 description 1
• 230000004540 complement-dependent cytotoxicity Effects 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 235000020028 corn beer Nutrition 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000006184 cosolvent Substances 0.000 description 1
• 230000004940 costimulation Effects 0.000 description 1
• 230000000139 costimulatory effect Effects 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 239000002385 cottonseed oil Substances 0.000 description 1
• 230000009260 cross reactivity Effects 0.000 description 1
• 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 238000002784 cytotoxicity assay Methods 0.000 description 1
• 231100000263 cytotoxicity test Toxicity 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000006240 deamidation Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 239000000032 diagnostic agent Substances 0.000 description 1
• 229940039227 diagnostic agent Drugs 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• 238000002050 diffraction method Methods 0.000 description 1
• 229940008099 dimethicone Drugs 0.000 description 1
• 239000004205 dimethyl polysiloxane Substances 0.000 description 1
• 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
• AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• 235000021186 dishes Nutrition 0.000 description 1
• CDMADVZSLOHIFP-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane;decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 CDMADVZSLOHIFP-UHFFFAOYSA-N 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 239000003534 dna topoisomerase inhibitor Substances 0.000 description 1
• 229960003668 docetaxel Drugs 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 101150010415 eat-5 gene Proteins 0.000 description 1
• 235000007124 elderberry Nutrition 0.000 description 1
• 239000012149 elution buffer Substances 0.000 description 1
• 208000014616 embryonal neoplasm Diseases 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 229940126588 endocrine therapeutic agent Drugs 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 229940088598 enzyme Drugs 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 208000032099 esthesioneuroblastoma Diseases 0.000 description 1
• 238000012869 ethanol precipitation Methods 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
• 229960005420 etoposide Drugs 0.000 description 1
• 235000008995 european elder Nutrition 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000005284 excitation Effects 0.000 description 1
• 238000010195 expression analysis Methods 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 201000010175 gallbladder cancer Diseases 0.000 description 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
• 239000003349 gelling agent Substances 0.000 description 1
• 229960005277 gemcitabine Drugs 0.000 description 1
• SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 230000036252 glycation Effects 0.000 description 1
• 229940049654 glyceryl behenate Drugs 0.000 description 1
• 125000003712 glycosamine group Chemical group 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 208000024348 heart neoplasm Diseases 0.000 description 1
• 208000025339 heart septal defect Diseases 0.000 description 1
• 230000002489 hematologic effect Effects 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 244000144980 herd Species 0.000 description 1
• 210000001624 hip Anatomy 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 201000008298 histiocytosis Diseases 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 238000011577 humanized mouse model Methods 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
• 238000012872 hydroxylapatite chromatography Methods 0.000 description 1
• 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
• 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
• 229940072106 hydroxystearate Drugs 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000037189 immune system physiology Effects 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 229910052738 indium Inorganic materials 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 150000002484 inorganic compounds Chemical class 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 201000002313 intestinal cancer Diseases 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 238000010212 intracellular staining Methods 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000005342 ion exchange Methods 0.000 description 1
• 229960005386 ipilimumab Drugs 0.000 description 1
• 201000002529 islet cell tumor Diseases 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• 229940074928 isopropyl myristate Drugs 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 210000000244 kidney pelvis Anatomy 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 206010023841 laryngeal neoplasm Diseases 0.000 description 1
• 210000000088 lip Anatomy 0.000 description 1
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 238000002961 luciferase induction Methods 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 201000000564 macroglobulinemia Diseases 0.000 description 1
• 229960003511 macrogol Drugs 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 239000000395 magnesium oxide Substances 0.000 description 1
• CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
• AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
• 229940049920 malate Drugs 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 208000020984 malignant renal pelvis neoplasm Diseases 0.000 description 1
• 208000026045 malignant tumor of parathyroid gland Diseases 0.000 description 1
• 229940035034 maltodextrin Drugs 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 235000013372 meat Nutrition 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 108091027597 miR-1d stem-loop Proteins 0.000 description 1
• 239000000693 micelle Substances 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
• 229960001156 mitoxantrone Drugs 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 208000008588 molluscum contagiosum Diseases 0.000 description 1
• RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
• 239000004223 monosodium glutamate Substances 0.000 description 1
• 235000013923 monosodium glutamate Nutrition 0.000 description 1
• 210000000214 mouth Anatomy 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 201000005962 mycosis fungoides Diseases 0.000 description 1
• 201000006462 myelodysplastic/myeloproliferative neoplasm Diseases 0.000 description 1
• 229940043348 myristyl alcohol Drugs 0.000 description 1
• RKISUIUJZGSLEV-UHFFFAOYSA-N n-[2-(octadecanoylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCNC(=O)CCCCCCCCCCCCCCCCC RKISUIUJZGSLEV-UHFFFAOYSA-N 0.000 description 1
• 229950006780 n-acetylglucosamine Drugs 0.000 description 1
• 210000004296 naive t lymphocyte Anatomy 0.000 description 1
• 210000003928 nasal cavity Anatomy 0.000 description 1
• 210000001989 nasopharynx Anatomy 0.000 description 1
• 230000037125 natural defense Effects 0.000 description 1
• 210000000581 natural killer T-cell Anatomy 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 201000008026 nephroblastoma Diseases 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 230000009835 non selective interaction Effects 0.000 description 1
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
• 230000009871 nonspecific binding Effects 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 239000002773 nucleotide Substances 0.000 description 1
• 125000003729 nucleotide group Chemical group 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 201000002575 ocular melanoma Diseases 0.000 description 1
• 239000003883 ointment base Substances 0.000 description 1
• 229940055577 oleyl alcohol Drugs 0.000 description 1
• XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
• 238000006384 oligomerization reaction Methods 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 229960001027 opium Drugs 0.000 description 1
• 201000006958 oropharynx cancer Diseases 0.000 description 1
• 201000008968 osteosarcoma Diseases 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 208000022102 pancreatic neuroendocrine neoplasm Diseases 0.000 description 1
• 208000003154 papilloma Diseases 0.000 description 1
• 208000029211 papillomatosis Diseases 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 208000007312 paraganglioma Diseases 0.000 description 1
• 201000003913 parathyroid carcinoma Diseases 0.000 description 1
• 235000015927 pasta Nutrition 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 229960005079 pemetrexed Drugs 0.000 description 1
• QOFFJEBXNKRSPX-ZDUSSCGKSA-N pemetrexed Chemical group C1=N[C]2NC(N)=NC(=O)C2=C1CCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QOFFJEBXNKRSPX-ZDUSSCGKSA-N 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 208000028591 pheochromocytoma Diseases 0.000 description 1
• 229940067631 phospholipid Drugs 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 239000002504 physiological saline solution Substances 0.000 description 1
• 208000010916 pituitary tumor Diseases 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 210000004180 plasmocyte Anatomy 0.000 description 1
• 229920001308 poly(aminoacid) Polymers 0.000 description 1
• 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
• 229920001583 poly(oxyethylated polyols) Polymers 0.000 description 1
• 229920002704 polyhistidine Polymers 0.000 description 1
• 229920001296 polysiloxane Polymers 0.000 description 1
• 229920000136 polysorbate Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 238000002203 pretreatment Methods 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 238000004393 prognosis Methods 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000001902 propagating effect Effects 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 239000001990 protein-drug conjugate Substances 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• 235000008001 rakum palm Nutrition 0.000 description 1
• 229920005604 random copolymer Polymers 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 239000000018 receptor agonist Substances 0.000 description 1
• 229940044601 receptor agonist Drugs 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000012121 regulation of immune response Effects 0.000 description 1
• 201000007444 renal pelvis carcinoma Diseases 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 238000004007 reversed phase HPLC Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 150000003335 secondary amines Chemical class 0.000 description 1
• 238000010187 selection method Methods 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 229940083037 simethicone Drugs 0.000 description 1
• 208000037968 sinus cancer Diseases 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 208000000587 small cell lung carcinoma Diseases 0.000 description 1
• 229940083538 smallpox vaccine Drugs 0.000 description 1
• 239000000344 soap Substances 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 230000000392 somatic effect Effects 0.000 description 1
• 235000019337 sorbitan trioleate Nutrition 0.000 description 1
• 229960000391 sorbitan trioleate Drugs 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 235000013599 spices Nutrition 0.000 description 1
• 206010062261 spinal cord neoplasm Diseases 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 238000004659 sterilization and disinfection Methods 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 208000003265 stomatitis Diseases 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 238000005728 strengthening Methods 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 101150047697 tagB gene Proteins 0.000 description 1
• DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 1
• 101150009385 tcpI gene Proteins 0.000 description 1
• 108010013645 tetranectin Proteins 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 230000035922 thirst Effects 0.000 description 1
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 208000008732 thymoma Diseases 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 229960000984 tocofersolan Drugs 0.000 description 1
• 229940044693 topoisomerase inhibitor Drugs 0.000 description 1
• 229960000303 topotecan Drugs 0.000 description 1
• UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 239000011573 trace mineral Substances 0.000 description 1
• 235000013619 trace mineral Nutrition 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• 229910052722 tritium Inorganic materials 0.000 description 1
• 208000029387 trophoblastic neoplasm Diseases 0.000 description 1
• 229940038237 tumor antigen vaccine Drugs 0.000 description 1
• 230000005740 tumor formation Effects 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241000007181 unidentified human coronavirus Species 0.000 description 1
• 201000011294 ureter cancer Diseases 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 206010046885 vaginal cancer Diseases 0.000 description 1
• 208000013139 vaginal neoplasm Diseases 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 229940046009 vitamin E Drugs 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 201000005102 vulva cancer Diseases 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 239000002023 wood Substances 0.000 description 1
• 239000000230 xanthan gum Substances 0.000 description 1
• 229920001285 xanthan gum Polymers 0.000 description 1
• 235000010493 xanthan gum Nutrition 0.000 description 1
• 229940082509 xanthan gum Drugs 0.000 description 1
• 229940051021 yellow-fever virus Drugs 0.000 description 1
• 239000002076 α-tocopherol Substances 0.000 description 1
• GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1